Literature DB >> 18972168

Comparison of surgically resected polypoid lesions of the gallbladder to their pre-operative ultrasound characteristics.

Martin D Zielinski1, Thomas D Atwell, Peyton W Davis, Michael L Kendrick, Florencia G Que.   

Abstract

BACKGROUND: Polypoid lesions of the gallbladder (PLG) have been a common finding on ultrasound examinations of the abdomen and are more prevalent since our use of equipment incorporating pulse shaping increased bandwidth, and enhanced phase use for image reconstruction began in 1996. Our study correlates the pre-operative ultrasonographic findings of these lesions to the surgically resected specimen with specific regard to identifying neoplastic polyps.
METHODS: A retrospective review was performed of 130 patients who had a pre-operative ultrasound of the gallbladder and subsequently underwent cholecystectomy between August 1996 and July 2007 at the Mayo Clinic Rochester.
RESULTS: Seventy-nine pseudopolyps (cholesterol polyps, inflammatory polyps, and adenomyomas) and 15 neoplastic polyps were identified on histopathologic analysis. However, 36 patients (27%) did not have a PLG upon histopathologic analysis. Thirty-one polyps had suspicious ultrasonographic characteristics for neoplastic changes. Twenty-nine were > or = 10 mm, 12 had vascularity, and one demonstrated invasion. Of these, there were 23 pseudopolyps and six true polyps with neoplastic changes on final pathology (four dysplastic adenomas and two adenocarcinomas). Three asymptomatic polyps < or = 10 mm (4%) in maximum diameter based on pre-operative ultrasound imaging (US) had neoplastic changes at pathology (two dysplastic adenomas and one adenocarcinoma). Several statistically significant risk factors were identified that increased the likelihood for malignancy in a PLG: history of primary sclerosing cholangitis (PSC), local invasion, vascularity, and > or = 6 mm maximum diameter based on pre-operative US. Of PLGs < or = 10 mm, 7.4% were neoplastic. Twenty-five patients were followed up with at least two serial ultrasound examinations. Of these, seven demonstrated polyp growth. None of these specimens demonstrated neoplastic changes. The positive predictive value (PPV) and negative predictive value (NPV) for ultrasound diagnosing neoplastic changes based on current criteria was 28.5% and 93.1%, respectively, with a false negative rate of 5.0%. Expanding the criteria to include cholecystectomy for PLGs > or = 6 mm changes the positive predictive value and negative predictive value to 18.5% and 100%, respectively, with a false negative rate of 0%.
CONCLUSION: Histopathologic analysis of polypoid lesions of the gallbladder continues to be the gold standard to identify malignancy. Ultrasound has been used extensively in the pre-operative management of these lesions, but modern ultrasound techniques are unable to differentiate between benign and malignant PLGs with any certainty. We recommend that strong consideration be given to surgical resection of PLGs > or = 6 mm based on pre-operative US due to the significant risk of neoplasm. Additionally, PLGs in all patients with PSC, any patient in whom diligent long-term follow-up cannot be completed, and lesions that demonstrate growth, vascularity, invasion, or are symptomatic require cholecystectomy.

Entities:  

Mesh:

Year:  2008        PMID: 18972168     DOI: 10.1007/s11605-008-0725-2

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  28 in total

1.  Question and answer. Sonographic follow-up of patients with gallbladder polyps.

Authors:  M E Tublin
Journal:  AJR Am J Roentgenol       Date:  2001-08       Impact factor: 3.959

2.  Polypoid lesions of the gallbladder: diagnosis and indications for surgery.

Authors:  H L Yang; Y G Sun; Z Wang
Journal:  Br J Surg       Date:  1992-03       Impact factor: 6.939

Review 3.  Management of gallbladder polyps.

Authors:  A W Mangel
Journal:  South Med J       Date:  1997-05       Impact factor: 0.954

4.  Ultrasonographic evidence of association of polyps and stones with gallbladder cancer.

Authors:  M Okamoto; H Okamoto; F Kitahara; K Kobayashi; K Karikome; K Miura; Y Matsumoto; M A Fujino
Journal:  Am J Gastroenterol       Date:  1999-02       Impact factor: 10.864

5.  Carcinoma in situ of the gallbladder: A dilemma.

Authors:  B A Bivins; W R Meeker; D L Weiss; W O Griffen
Journal:  South Med J       Date:  1975-03       Impact factor: 0.954

6.  Can endoscopic ultrasonography differentiate nonneoplastic from neoplastic gallbladder polyps?

Authors:  Tomotaka Akatsu; Koichi Aiura; Motohide Shimazu; Masakazu Ueda; Go Wakabayashi; Minoru Tanabe; Shigeyuki Kawachi; Masaki Kitajima
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

7.  Carcinoma of the gallbladder. A clinicopathology of 103 patients and a newly proposed staging.

Authors:  K Yamaguchi; M Enjoji
Journal:  Cancer       Date:  1988-10-01       Impact factor: 6.860

8.  Large cholesterol polyps of the gallbladder: diagnosis by means of US and endoscopic US.

Authors:  M Sugiyama; Y Atomi; A Kuroda; T Muto; N Wada
Journal:  Radiology       Date:  1995-08       Impact factor: 11.105

9.  The difference in malignancy between pedunculated and sessile polypoid lesions of the gallbladder.

Authors:  O Ishikawa; H Ohhigashi; S Imaoka; A Nakaizumi; T Kitamura; Y Sasaki; T Shibata; A Wada; T Iwanaga
Journal:  Am J Gastroenterol       Date:  1989-11       Impact factor: 10.864

10.  Relation of adenoma to carcinoma in the gallbladder.

Authors:  S Kozuka; N Tsubone; A Yasui; K Hachisuka
Journal:  Cancer       Date:  1982-11-15       Impact factor: 6.860

View more
  21 in total

1.  SAGES guidelines for the clinical application of laparoscopic biliary tract surgery.

Authors:  D Wayne Overby; Keith N Apelgren; William Richardson; Robert Fanelli
Journal:  Surg Endosc       Date:  2010-08-13       Impact factor: 4.584

2.  The diagnostic accuracy of transabdominal ultrasonography needs to be considered when managing gallbladder polyps.

Authors:  Daniel G French; Philippe D Allen; James C Ellsmere
Journal:  Surg Endosc       Date:  2013-06-08       Impact factor: 4.584

3.  The Mucocele of the Gallbladder.

Authors:  Gennaro Clemente; Valeria Fico; Davide De Sio; Agostino Maria De Rose
Journal:  J Gastrointest Surg       Date:  2017-03-20       Impact factor: 3.452

4.  Gallbladder lesions identified on ultrasound. Lessons from the last 10 years.

Authors:  Ioannis T Konstantinidis; Surabhi Bajpai; Avinash R Kambadakone; Kenneth K Tanabe; David L Berger; Hui Zheng; Dushyant V Sahani; Gregory Y Lauwers; Carlos Fernandez-del Castillo; Andrew L Warshaw; Cristina R Ferrone
Journal:  J Gastrointest Surg       Date:  2011-11-23       Impact factor: 3.452

Review 5.  Diagnostic accuracy of transabdominal ultrasonography for gallbladder polyps: systematic review.

Authors:  Erin Martin; Richdeep Gill; Estifanos Debru
Journal:  Can J Surg       Date:  2018-06       Impact factor: 2.089

6.  Gallbladder polyps: factors affecting surgical decision.

Authors:  Pinar Sarkut; Sadik Kilicturgay; Ali Ozer; Ersin Ozturk; Tuncay Yilmazlar
Journal:  World J Gastroenterol       Date:  2013-07-28       Impact factor: 5.742

Review 7.  Cancer surveillance in patients with primary sclerosing cholangitis.

Authors:  Nataliya Razumilava; Gregory J Gores; Keith D Lindor
Journal:  Hepatology       Date:  2011-11       Impact factor: 17.425

8.  Polypoid lesions of the gallbladder: analysis of 1204 patients with long-term follow-up.

Authors:  Shu-Cheng Chou; Shih-Chin Chen; Yi-Ming Shyr; Shin-E Wang
Journal:  Surg Endosc       Date:  2016-12-30       Impact factor: 4.584

9.  Treatment and surveillance of polypoid lesions of the gallbladder in the United Kingdom.

Authors:  Gabriele Marangoni; Abdul Hakeem; Giles J Toogood; J Peter A Lodge; K Raj Prasad
Journal:  HPB (Oxford)       Date:  2012-05-11       Impact factor: 3.647

10.  Malignancies in Primary Sclerosing Cholangitis--A Continuing Threat.

Authors:  Giulia Bonato; Laura Cristoferi; Mario Strazzabosco; Luca Fabris
Journal:  Dig Dis       Date:  2015-12-07       Impact factor: 2.404

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.